CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Operating activities:
Net income attributable to common shareholders	$ 228.9	$ 192.7	$ 219.5
Noncontrolling interest in subsidiaries' earnings	1.1	0.9	1.4
Net income before allocation to noncontrolling interests	230.0	193.6	220.9
Asbestos Provision	0.0	0.0	0.0
Environmental provision	0.0	55.8	0.0
Gain on divestiture	0.0	(4.1)	(2.7)
Restructuring - Non Cash	2.0	1.0	0.0
Depreciation and amortization	67.0	75.8	54.8
Stock-based compensation expense	21.3	20.9	22.8
Defined benefit plans and postretirement (credit) expense	(11.6)	(11.5)	4.8
Deferred income taxes	39.7	37.9	49.0
Cash provided by (used for) operating working capital	(16.1)	22.5	(26.7)
Defined benefit plans and postretirement contributions	(17.9)	(25.5)	(15.9)
Payments for Environmental Liabilities	(18.2)	(10.4)	(15.4)
Payments for asbestos-related fees and costs, net of insurance recoveries	(49.9)	(61.3)	(62.8)
Other	17.0	30.7	(10.6)
Total provided by operating activities	229.3	264.0	239.4
Investing activities:
Capital expenditures	(39.6)	(43.7)	(29.5)
Proceeds from disposition of capital assets	4.4	9.7	0.5
Proceeds from (payments for) acquisitions	0.0	2.1	6.8
Payments to Acquire Businesses, Net of Cash Acquired	0.0	6.1	(801.8)
Total used for investing activities	(35.2)	(25.8)	(824.0)
Equity:
Dividends paid	(76.6)	(73.9)	(67.3)
Reacquisition of shares on open market	(25.0)	(50.0)	0.0
Stock options exercised - net of shares reacquired	8.9	8.2	24.9
Excess tax benefit from stock-based compensation	0.1	7.7	6.4
Proceeds from Lines of Credit	0.0	0.0	125.0
Debt:
Proceeds received from issuance of long-term notes	(100.0)	(25.0)	(0.3)
Proceeds from (Repayments of) Commercial Paper	48.8
Proceeds from Issuance of Long-term Debt	0.0	0.0	550.0
Payments of Debt Issuance Costs	0.0	0.0	(6.0)
Repayments of Long-term Debt	0.0	0.0	(200.0)
Total (used for) provided by financing activities	(143.8)	(133.0)	432.7
Effect of exchange rates on cash and cash equivalents	(33.1)	(29.5)	(1.4)
Increase (decrease) in cash and cash equivalents	17.2	75.7	(153.3)
Cash and cash equivalents at beginning of period	346.3	270.6	423.9
Cash and cash equivalents at end of period	363.5	346.3	270.6
Detail of cash used for working capital:
Accounts receivable	(2.4)	25.2	(42.9)
Inventories	(23.0)	(17.3)	28.1
Other current assets	(3.0)	1.8	2.9
Accounts payable	3.3	7.7	18.0
Accrued liabilities	6.1	2.7	(28.9)
U.S. and foreign taxes on income	2.9	2.4	(3.9)
Total	(16.1)	22.5	(26.7)
Supplemental disclosure of cash flow information:
Interest paid	37.5	39.4	28.2
Income taxes paid	$ 51.1	$ 39.6	$ 53.7